Blaxhult A - Search Results

1

A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study.

Lundgren JD, Mocroft A, Gatell JM, Ledergerber B, D'Arminio Monforte A, Hermans P, Goebel FD, Blaxhult A, Kirk O, Phillips AN; EuroSIDA Study Group. Lundgren JD, et al. Among authors: blaxhult a. J Infect Dis. 2002 Jan 15;185(2):178-87. doi: 10.1086/338267. Epub 2002 Jan 3. J Infect Dis. 2002. PMID: 11807691 Free article.

2

Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons.

Shepherd L, Souberbielle JC, Bastard JP, Fellahi S, Capeau J, Reekie J, Reiss P, Blaxhult A, Bickel M, Leen C, Kirk O, Lundgren JD, Mocroft A, Viard JP; EuroSIDA in EuroCOORD. Shepherd L, et al. Among authors: blaxhult a. J Infect Dis. 2014 Jul 15;210(2):234-43. doi: 10.1093/infdis/jiu074. Epub 2014 Feb 3. J Infect Dis. 2014. PMID: 24493824

3

Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: a retrospective cohort study.

Jensen-Fangel S, Kirk O, Larsen L, Blaxhult A, Gerstoft J, Pedersen C, Black FT, Lundgren JD, Obel N. Jensen-Fangel S, et al. Among authors: blaxhult a. Scand J Infect Dis. 1999;31(5):489-93. doi: 10.1080/00365549950164021. Scand J Infect Dis. 1999. PMID: 10576129

4

Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study.

Mocroft A, Monforte Ad, Kirk O, Johnson MA, Friis-Moller N, Banhegyi D, Blaxhult A, Mulcahy F, Gatell JM, Lundgren JD; EuroSIDA study group. Mocroft A, et al. Among authors: blaxhult a. HIV Med. 2004 Nov;5(6):437-47. doi: 10.1111/j.1468-1293.2004.00250.x. HIV Med. 2004. PMID: 15544697 Free article.

5

Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.

Holkmann Olsen C, Mocroft A, Kirk O, Vella S, Blaxhult A, Clumeck N, Fisher M, Katlama C, Phillips AN, Lundgren JD; EuroSIDA study group. Holkmann Olsen C, et al. Among authors: blaxhult a. HIV Med. 2007 Mar;8(2):96-104. doi: 10.1111/j.1468-1293.2007.00436.x. HIV Med. 2007. PMID: 17352766 Free article.

6

A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival.

Mocroft A, Madge S, Johnson AM, Lazzarin A, Clumeck N, Goebel FD, Viard JP, Gatell J, Blaxhult A, Lundgren JD. Mocroft A, et al. Among authors: blaxhult a. J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):369-78. doi: 10.1097/00126334-199912010-00008. J Acquir Immune Defic Syndr. 1999. PMID: 10634199

7

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

Data Collection on Adverse Events of Anti-HIV Drugs Study Group; Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD. Data Collection on Adverse Events of Anti-HIV Drugs Study Group, et al. Clin Infect Dis. 2008 Apr 1;46(7):1101-10. doi: 10.1086/528862. Clin Infect Dis. 2008. PMID: 18461712 Free PMC article.

8

Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe.

Zoufaly A, Cozzi-Lepri A, Reekie J, Kirk O, Lundgren J, Reiss P, Jevtovic D, Machala L, Zangerle R, Mocroft A, Van Lunzen J; EuroSIDA in EuroCoord. Zoufaly A, et al. PLoS One. 2014 Jan 31;9(1):e87160. doi: 10.1371/journal.pone.0087160. eCollection 2014. PLoS One. 2014. PMID: 24498036 Free PMC article.

9

Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.

Mocroft A, Gatell J, Reiss P, Ledergerber B, Kirk O, Vella S, Blaxhult A, Phillips AN, Lundgren J; EuroSIDA study group. Mocroft A, et al. Among authors: blaxhult a. AIDS. 2004 Nov 19;18(17):2333-7. doi: 10.1097/00002030-200411190-00018. AIDS. 2004. PMID: 15577550

10

Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection.

Kowalska JD, Mocroft A, Blaxhult A, Colebunders R, van Lunzen J, Podlekareva D, Hansen AB, Machala L, Yust I, Benfield T; EuroSIDA Study Group. Kowalska JD, et al. Among authors: blaxhult a. AIDS Res Hum Retroviruses. 2007 Oct;23(10):1183-8. doi: 10.1089/aid.2006.0292. AIDS Res Hum Retroviruses. 2007. PMID: 17961102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page